Metabolic adaptation of lymphocytes in immunity and disease

NM Chapman, H Chi - Immunity, 2022 - cell.com
Adaptive immune responses mediated by T cells and B cells are crucial for protective
immunity against pathogens and tumors. Differentiation and function of immune cells require …

Oncogenic pathways and the electron transport chain: a dangeROS liaison

V Raimondi, F Ciccarese, V Ciminale - British journal of cancer, 2020 - nature.com
Driver mutations in oncogenic pathways, rewiring of cellular metabolism and altered ROS
homoeostasis are intimately connected hallmarks of cancer. Electrons derived from different …

Integrating network pharmacology deciphers the action mechanism of Zuojin capsule in suppressing colorectal cancer

J Fan, M Xu, L Zhou, Z Gui, L Huang, X Li, X Ye - Phytomedicine, 2022 - Elsevier
Background and purpose Zuojin capsule (ZJC), a classical prescription, is outstanding in
improving the conditions of patients with gastrointestinal diseases and colorectal cancer …

Complete remission of a diffuse large B-cell lymphoma in a young patient, with severe tuberous sclerosis, treated with metronomic chemotherapy and ibrutinib: a case …

M Banchi, T Lanzolla, A Di Napoli, A Bandini, G Bocci… - Chemotherapy, 2024 - karger.com
Tuberous sclerosis (TS) is a rare autosomal dominant genetic multisystem disease caused
by mutations in either the TSC1 or TSC2 gene and results in the growth of non-cancerous …

Tuberous sclerosis complex 1 (PvTSC1) participates in ammonia nitrogen induced oxidative stress in Penaeus vannamei by regulating autophagy

F Wang, Q Liang, C Liu, W Dong, M Ou, Z Li, Y Liu… - Aquaculture, 2021 - Elsevier
The tuberous sclerosis complex 1 (TSC1) is a critical upstream regulator of autophagy.
Nevertheless, the detailed molecular mechanism of TSC1 and its function in crustacean are …

Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

R Winkler, EM Piskor, C Kosan - Cells, 2022 - mdpi.com
Oncogenic overexpression of MYC leads to the fatal deregulation of signaling pathways,
cellular metabolism, and cell growth. MYC rearrangements are found frequently among non …

[HTML][HTML] La vía canónica PI3K/AKT/mTOR y sus alteraciones en cáncer

F Aldecoa, J Ávila - Horizonte Médico (Lima), 2021 - scielo.org.pe
La vía PI3K/AKT/mTOR participa en múltiples procesos celulares fundamentales para la
célula. Algunas mutaciones genéticas de los componentes de esta vía se han asociado a …

The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental Verification

F Liu, J Li, B Zhou, Y Shen, J Tang… - … Chemistry & High …, 2024 - ingentaconnect.com
Background and Purpose: Emodin, a compound derived from rhubarb and various
traditional Chinese medicines, exhibits a range of pharmacological actions, including …

[HTML][HTML] Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex–associated cystic kidney disease

M Nechama, Y Makayes, E Resnick, K Meir… - JCI insight, 2020 - ncbi.nlm.nih.gov
Chronic kidney disease is the main cause of mortality in patients with tuberous sclerosis
complex (TSC) disease. The mechanisms underlying TSC cystic kidney disease remain …

N-myristoyltransferase inhibition is synthetic lethal in MYC-deregulated cancers

GA Lueg, M Faronato, A Gorelik, AG Grocin… - bioRxiv, 2021 - biorxiv.org
Human N-myristoyltransferases (NMTs) catalyze N-terminal protein myristoylation, a
modification regulating membrane trafficking and interactions of> 100 proteins. NMT is a …